Bone Regeneration Using Mesenchymal Stem Cells: Challenges and Future Perspectives in Regenerative Surgery
2015; Future Medicine; Volume: 10; Issue: 5 Linguagem: Inglês
10.2217/rme.15.35
ISSN1746-076X
AutoresMaja Sabali, Alessandro Mangano, Georgios D. Lianos, Luigi Boni, Gianlorenzo Dionigi, Alberto Mangano,
Tópico(s)Tissue Engineering and Regenerative Medicine
ResumoRegenerative MedicineVol. 10, No. 5 CommentaryBone regeneration using mesenchymal stem cells: challenges and future perspectives in regenerative surgeryMaja Sabali, Alessandro Mangano, Georgios D Lianos, Luigi Boni, Gianlorenzo Dionigi & Alberto ManganoMaja Sabali Department of Craniofacial Development & Stem Cell Biology, King's College London Dental Institute, Floor 27, Tower, Guy's Hospital London, SE1 9RT, UK, Alessandro Mangano Private Practice in Gravedona ed Uniti (CO), Italy, Georgios D Lianos Center for Biosystems & Genomic Network Medicine – CBS.GenNetMed, University of Ioannina, Ioannina, GR 451 10, Greece Department of Surgery, University of Ioannina, Ioannina, GR 451 10, Greece, Luigi Boni Department of Surgical Sciences & Human Morphology, Insubria University Vares-Como, 1st Division of General Surgery Ospedale di Circolo e Fondazione Macchi, Viale Luigi Borri 57, 21100 Varese, Italy, Gianlorenzo Dionigi Department of Surgical Sciences & Human Morphology, Insubria University Vares-Como, 1st Division of General Surgery Ospedale di Circolo e Fondazione Macchi, Viale Luigi Borri 57, 21100 Varese, Italy & Alberto Mangano*Author for correspondence: E-mail Address: alberto.mangano@gmail.com Department of Surgical Sciences & Human Morphology, Insubria University Vares-Como, 1st Division of General Surgery Ospedale di Circolo e Fondazione Macchi, Viale Luigi Borri 57, 21100 Varese, Italy Ospedale di Circolo e Fondazione Macchi, Viale Luigi Borri 57, 21100 Varese, ItalyPublished Online:3 Aug 2015https://doi.org/10.2217/rme.15.35AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: bone regenerationgrowth factorsmesenchymal stem cellsregenerative surgeryscaffoldstissue engineeringReferences1 Raposo-Amaral CE, Bueno DF, Almeida AB et al. Is bone transplantation the gold standard for repair of alveolar bone defects? J. Tissue Eng. doi:10.1177/2041731413519352 (2014) (Epub ahead of print).Crossref, Medline, Google Scholar2 Dimitriou R, Mataliotakis GI, Angoules AG, Kanakaris NK, Giannoudis PV. Complications following autologous bone graft harvesting from the iliac crest and using the RIA: a systematic review. Injury 42(Suppl. 2), S3–S15 (2011).Crossref, Medline, Google Scholar3 Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell 126, 677–689 (2006).Crossref, Medline, CAS, Google Scholar4 Li X, Wang L, Fan Y, Feng Q, Cui FZ, Watari F. Nanostructured scaffolds for bone tissue engineering. J. Biomed. Mater. Res. A 101, 2424–2435 (2013).Crossref, Medline, Google Scholar5 Wang P, Zhao L, Liu J, Weir MD, Zhou X, Hockin HK. XuBone tissue engineering via nanostructured calcium phosphate biomaterials and stem cells. 2, 14017 (2014).Google Scholar6 Gnecchi M, He H, Liang OD et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 11, 367–368 (2005).Crossref, Medline, CAS, Google Scholar7 Osugi M, Katagiri W, Yoshimi R, Inukai T, Hibi H, Ueda M. Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects. Tissue Eng. A 18, 1479–1489 (2012).Crossref, Medline, CAS, Google Scholar8 Kawai T, Katagiri W, Osugi M, Sugimura Y, Hibi H, Ueda M. Secretomes from bone marrow derived mesenchymal stromal cells enhance periodontal tissue regeneration. Cytotherapy 17(4), 369–381 (2015).Crossref, Medline, CAS, Google Scholar9 Chan CK, Seo EY, Chen JY et al. Identification and specification of the mouse skeletal stem cell. Cell 160, 285–298 (2015).Crossref, Medline, CAS, Google Scholar10 Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315–317 (2006).Crossref, Medline, CAS, Google Scholar11 Kassem M, Bianco P. Skeletal stem cells in space and time. Cell 160, 17–19 (2015).Crossref, Medline, CAS, Google Scholar12 Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17, 331–340 (1974).Crossref, Medline, CAS, Google Scholar13 Worthley DL, Churchill M, Compton JT et al. Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential. Cell 160, 269–284 (2015).Crossref, Medline, CAS, Google Scholar14 Gallegos TF, Sancho-Martinez I, Izpisua Belmonte JC. Advances in cellular reprogramming: moving toward a reprieve from immunogenicity. Immunol. Lett. 155, 14–7 (2013).Crossref, Medline, CAS, Google Scholar15 González F, Boué S, Izpisúa Belmonte JC. Methods for making induced pluripotent stem cells: reprogramming à la carte. Nat. Rev. Genet. 12, 231–242 (2011).Crossref, Medline, CAS, Google Scholar16 Gore A, Li Z, Fung HL et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 470, 63–67 (2011).Crossref, Google Scholar17 Barkholt L, Flory E, Jekerle V et al. Risk of tumorigenicity in mesenchymal stromal cell-based therapies–bridging scientific observations and regulatory viewpoints. Cytotherapy 15, 753–759 (2013).Crossref, Medline, Google Scholar18 Jung Y, Bauer G, Nolta JA. Concise review: induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells 30, 42–47 (2012).Crossref, Medline, CAS, Google Scholar19 Wang P, Liu X, Zhao L et al. Bone tissue engineering via human induced pluripotent, umbilical cord and bone marrow mesenchymal stem cells in rat cranium. Acta Biomater. 18, 236–248 (2015).Crossref, Medline, CAS, Google Scholar20 Berner A, Reichert JC, Woodruff MA et al. Autologous vs. allogenic mesenchymal progenitor cells for the reconstruction of critical sized segmental tibial bone defects in aged sheep. Acta Biomater. 9, 7874–7884 (2013).Crossref, Medline, CAS, Google Scholar21 Feng J, Mantesso A, De Bari C, Nishiyama A, Sharpe PT. Dual origin of mesenchymal stem cells contributing to organ growth and repair. Proc. Natl Acad. Sci. USA 108, 6503–6508 (2011).Crossref, Medline, CAS, Google Scholar22 Kaukua N, Shahidi MK, Konstantinidou C et al. Glial origin of mesenchymal stem cells in a tooth model system. Nature 513(7519), 551–554 (2014).Crossref, Medline, CAS, Google Scholar23 Kramann R, Schneider RK, DiRocco DP et al. Perivascular Gli1+ progenitors are key contributors to injury – induced organ fibrosis. Cell Stem Cell 16(1), 51–66 (2015).Crossref, Medline, CAS, Google Scholar24 Van Der Sanden B, Dhobb M, Berger F, Wion D. Optimizing stem cell culture. J. Cell. Biochem. 111, 801–807 (2010).Crossref, Medline, CAS, Google Scholar25 Mangano A, Mangano A, Lianos GD, Picone M, Dionigi G. Tgf-β superfamily, molecular signaling and biomimetic features for bone regeneration: historical perspectives and future applications. Updates Surg. doi:10.1007/s13304-015-0297-0 (2015) (Epub ahead of print).Crossref, Google ScholarFiguresReferencesRelatedDetailsCited ByMitochondria transfer enhances proliferation, migration, and osteogenic differentiation of bone marrow mesenchymal stem cell and promotes bone defect healing25 June 2020 | Stem Cell Research & Therapy, Vol. 11, No. 1Application of platelet-rich plasma with stem cells in bone and periodontal tissue engineering13 December 2016 | Bone Research, Vol. 4, No. 1 Vol. 10, No. 5 Follow us on social media for the latest updates Metrics Downloaded 194 times History Published online 3 August 2015 Published in print August 2015 Information© Future Medicine LtdKeywordsbone regenerationgrowth factorsmesenchymal stem cellsregenerative surgeryscaffoldstissue engineeringFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download
Referência(s)